Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization)

被引：0
作者：
Ralf Thorsten Hoffmann
P. Paprottka
T. F. Jakobs
C. G. Trumm
M. F. Reiser
机构：
[1] University Hospital of Dresden,Institute and Clinic for Radiology
[2] University of Munich,Institute of Clinical Radiology
来源：
Abdominal Imaging | 2011年 / 36卷
关键词：
Transarterial chemoembolization; Radioembolization; Selective internal radiotherapy; Neuroendocrine tumors; Breast cancer; Malignant melanoma; Pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Treatment of primary and secondary hepatic malignancies with transarterial chemoembolization (TACE) represents an essential component of interventional oncology known for many years and performed by many interventional radiologists first in primary liver tumors and nowadays even in metastases of different origins. Radioembolization (RE) has been introduced to the clinical arsenal of cytoreductive modalities in recent years. There is growing evidence for efficiency in liver tumors of various entities, with the most prominent ones being hepatocellular carcinoma, colorectal cancer, and neuroendocrine tumors. Hepatic metastases of other tumor entities (breast cancer, malignant melanoma, and pancreatic cancer) are treatment-sensitive. This article focuses on procedural and technical aspects for selection, preparation, and performance of treatment as well as the results in metastatic breast cancer, neuroendocrine tumors, melanoma, and pancreatic cancer giving an overview of the results after RE, transarterial embolization, or TACE.
引用
收藏
页码：671 / 676
页数：5
相关论文
共 46 条
[11]  
Chen MS(2004)Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer J Gastroenterol Hepatol 19 347-349
[12]  
Higashi S(1998)Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres Int J Radiat Oncol Biol Phys 40 583-592
[13]  
Touzios JG(2009)Radiologic findings following Y90 radioembolization for primary liver malignancies Abdom Imaging 34 566-581
[14]  
Yip D(2009)Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review J Vasc Interv Radiol 20 1121-1130
[15]  
Lau WY(1973)An autopsy study of some routes of dissemination of cancer of the breast Br J Cancer 27 336-340
[16]  
Ibrahim SM(2004)Chemoembolization of liver metastasis from breast carcinoma J Vasc Interv Radiol 15 289-291
[17]  
Nikolaidis P(2008)Radioembolization in patients with hepatic metastases from breast cancer J Vasc Interv Radiol 19 683-690
[18]  
Miller FG(2007)90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival J Vasc Interv Radiol 18 621-628
[19]  
Riaz A(2007)Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer Int J Radiat Oncol Biol Phys 69 800-804
[20]  
Viadana E(2008)Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization J Vasc Interv Radiol 19 145-151
12345